Blencowe Resources: Aspiring to become one of the largest graphite producers in the world. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHaydale Regulatory News (HAYD)

Share Price Information for Haydale (HAYD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.46
Bid: 0.45
Ask: 0.47
Change: 0.00 (0.00%)
Spread: 0.02 (4.444%)
Open: 0.46
High: 0.46
Low: 0.46
Prev. Close: 0.46
HAYD Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

iCraft Order and Global Exclusivity Contract

9 Sep 2020 07:01

RNS Number : 4026Y
Haydale Graphene Industries PLC
09 September 2020
 

 

RNS REACH

 

For immediate release

9 September 2020

 

 

Haydale Graphene Industries plc

 

('Haydale' or the 'Group')

 

iCraft Place Order for Haydale Graphene Nano-Platelets and Sign Global Exclusivity Contract

 

Haydale, (AIM: HAYD), the global advanced materials group, is pleased to announce that, further to the announcement on 4th March 2020 regarding its graphene nano-platelets having been incorporated into iCraft's cosmetic face mask sheet; a contract is now in place for 1 metric tonne of graphene nano-platelets (GNP-02-STD) in the first year, 2 metric tonnes in the second year, and three metric tonnes in the third year. This is an exclusive agreement for the mask application within the APAC region, excluding Thailand.

 

Haydale has now signed a worldwide exclusivity contract to supply functionalised graphene nano-platelets for use in these sheet masks are face-shaped sheet fabrics which utilise the thermal and electrical conductivity of graphene to help the skin absorb its contents through bioelectric currents.

 

iCraft, based in South Korea, is a global technology company with interests in security and network solutions as well as the health and beauty sector. Following intense research and rigorous testing, iCraft is pleased to report zero harmful substances for graphene-based products, and has applied for three related patents.

 

Derek Yoon, iCraft, General Manager, said: "We value our relationship with Haydale. Through a steady relationship for more than a year, Graphene products have been successfully launched in the Korean market. Currently, our Graphene cosmetic face mask is being supplied to a famous domestic cosmetic company. Our Graphene sheet mask is also known as Korean cosmetics are popular abroad, especially in Asia cosmetic market. As sales volume is expected to increase steadily in the future, the partnership with Haydale will be more important. We look forward to Haydale and iCRAFT growing together."

Keith Broadbent, Haydale CEO, said: "We are pleased to see the contract with iCraft develop, with further materials being used in the health and beauty sector. Through this exclusivity contract, we expect to see these cosmetic face mask sheets commercialise globally."

 

- Ends -

 

 

 

 

For further information:

Haydale Graphene Industries plc

 

Keith Broadbent, CEO

Tel: +44 (0) 1269 842 946

Gemma Smith, Global Head of Marketing

www.haydale.com

 

 

Arden Partners plc (Nominated Adviser & Broker)

 

Ruari McGirr / Paul Shackleton / Ben Cryer

Tel: +44 (0) 20 7614 5900

 

Notes to Editors

Haydale is a global technologies and materials group that facilitates the integration of graphene and other nanomaterials into the next generation of commercial technologies and industrial materials. With expertise in graphene, silicon carbide and other nanomaterials, Haydale is able to deliver improvements in electrical, thermal and mechanical properties, as well as toughness. Haydale has granted patents for its technologies in Europe, USA, Australia, Japan and China and operates from six sites in the UK, USA and the Far East.

For more information please visit: www.haydale.com 

Twitter: @haydalegraphene 

 

iCraft is a KOSDAQ listed company whose primary business designs, develops, and provides internet network integration products. iCRAFT also develops innovative products in wider sectors such as health and beauty.

 

About RNS Reach announcements

This is an RNS Reach announcement. RNS Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute non-regulatory news releases into the public domain. Information required to be notified under the AIM Rules for Companies, Market Abuse Regulation or other regulation would be disseminated as an RNS regulatory announcement and not on RNS Reach.

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Private Policy.
 
END
 
 
NRAFFFIVALITIII
Date   Source Headline
2nd May 20247:00 amRNSGrant of Share Options and PDMR Dealing
12th Mar 20247:00 amRNSInterim Results
26th Jan 20247:00 amRNSGrant of Options & Surrender of Existing Options
22nd Jan 20247:00 amRNSHaydale selected for Innovate UK Scaleup Programme
7th Dec 202311:36 amRNSResult of AGM
7th Dec 202311:34 amRNSDirectorate Change
6th Dec 20237:00 amRNSHaydale awarded SMART funding
16th Nov 20232:31 pmRNSHolding(s) in Company
13th Nov 20237:00 amRNSPosting of Annual Report & Notice of AGM
1st Nov 20237:00 amRNSTotal Voting Rights
26th Oct 20237:00 amRNSFinal Results
9th Oct 20238:23 amRNSHolding(s) in Company
5th Oct 20231:43 pmRNSDirector/PDMR Shareholding & Total Voting Rights
4th Oct 20234:46 pmRNSHolding(s) in Company
3rd Oct 20233:48 pmRNSResult of General Meeting
2nd Oct 20237:00 amRNSTotal Voting Rights
22nd Sep 20234:30 pmRNSResult of Retail Offer and Total Voting Rights
15th Sep 20236:12 pmRNSResult of Fundraising
15th Sep 20234:00 pmRNSLaunch of Retail Offer
15th Sep 20233:00 pmRNSProposed Placing, Subscription & Retail Offer
15th Sep 20237:00 amRNSWarrant Expiry, Block Admission Cancellation & TVR
22nd Aug 20237:00 amRNSCollaboration with PETRONAS
4th Aug 20231:02 pmRNSHolding(s) in Company
2nd Aug 20237:00 amRNSDirectorate Change
24th Jul 20237:00 amRNSContract Award
13th Jul 20237:00 amRNSHaydale Delivers LPHW Prototype for Cadent
21st Jun 20237:00 amRNSTrading Update
5th Jun 20237:00 amRNSDirectorate Change
24th May 20237:00 amRNSHaydale to Contribute to the Development of FCHEVs
3rd May 20237:00 amRNSSMART Innovation to Accelerate Graphene Products
26th Apr 20233:06 pmRNSGrant of Share Options
12th Apr 20237:00 amRNSHaydale and Saint-Gobain Collaborate on hBN
16th Mar 20237:00 amRNSHaydale and City Energy Develop UFH with Plumbase
14th Mar 20238:15 amRNSBlock listing Interim Review
10th Mar 202311:05 amRNSSecond Price Monitoring Extn
10th Mar 202311:00 amRNSPrice Monitoring Extension
10th Mar 20237:00 amRNSDirectorate Change
1st Mar 20237:00 amRNSInterim Results
28th Feb 202311:38 amRNSHaydale and GEIC Proud to Partner for a Sixth Year
21st Feb 20237:00 amRNSRega Turns to Graphene to Improve Sound Quality
14th Feb 20237:00 amRNSInnovate UK Grant to Image 2D Materials Awarded
7th Feb 20237:00 amRNSHaydale Paddles Forward with Norse Kayaks
30th Jan 20237:00 amRNSNotice of Interim Results
26th Jan 20237:00 amRNSCeramycGuard™ on Trial with United Utilities
20th Dec 20227:00 amRNSGraphene-Enhanced Prepreg Extends Tool Life
1st Dec 20227:00 amRNSFinalist for Collaborate to Innovate Awards
30th Nov 20229:22 amRNSGrant of Warrants
29th Nov 20221:55 pmRNSResult of AGM
15th Nov 20227:00 amRNSGrant of share options and PDMR dealings
1st Nov 20227:00 amRNSDirectorate Change and Posting of Annual Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.